PfizerItem # 234401MPN 02344-01

Dobutamine 12.5 mg/mL 250 mg/20 mL 20 mL SDV, 1/Box

In StockPrescription required

UOM

BoxCase of 10

This item is prescription-controlled. A valid medical license must be on file for your account before it can be ordered.

Dobutamine Injection, USP

Dobutamine Injection, USP is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of adults with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures.

Unit of Use NDC 00409-2344-01

Unit of Sale NDC 00409-2344-01

Concentration 12.5 mg/mL

Content 250 mg/20 mL

20 ml Single-dose Vial (Solution)

Non-DEHP

Manufacturer: Pfizer
Sold By: Box of 1

What should I consider when administering Dobutamine for cardiac support compared to other inotropes?

When administering Dobutamine, consider its rapid onset and specific indication for short-term inotropic support in cardiac decompensation, which differs from other inotropes that may have longer durations or different hemodynamic effects. [Manufacturer Info]

Are there any specific storage requirements for the Dobutamine 12.5 mg/mL 20 mL SDV to ensure its effectiveness?

Dobutamine should be stored in controlled room temperatures; avoid excessive heat and protect from freezing to maintain its effectiveness. [Product Specs]

How quickly can one expect to see the effects of this Dobutamine injection on a patient's cardiac output?

The effects of Dobutamine on increasing cardiac output are typically observed within minutes of administration, making it suitable for rapid cardiac support. [Manufacturer Info]

What are the potential side effects or risks associated with using Dobutamine in patients with cardiac decompensation?

Potential side effects of Dobutamine include increased heart rate, arrhythmias, and blood pressure changes; monitoring is essential to manage these risks effectively. [Manufacturer Info]

For healthcare providers using this product for the first time, what are the key administration tips to ensure safety and efficacy?

Key administration tips include adhering to recommended dosages, monitoring patient response for efficacy and adverse effects, and ensuring proper storage and handling of the vial. [Manufacturer Info][Product Specs]

Dobutamine 12.5 mg/mL 250 mg/20 mL 20 mL SDV, 1/Box

Dobutamine 12.5 mg/mL 250 mg/20 mL 20 mL SDV, 1/Box

Dobutamine 12.5 mg/mL 250 mg/20 mL 20 mL SDV, 1/Box

Frequently bought together

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Propofol 200 mg/20 mL 10 mg/mL 20 mL SDV, 25/Bx

Amidate 40 mg/20 mL 2 mg/mL 20 mL SDV, 10/Bx

Dobutamine 12.5 mg/mL 250 mg/20 mL 20 mL SDV, 1/Box

Frequently bought together

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Propofol 200 mg/20 mL 10 mg/mL 20 mL SDV, 25/Bx

Amidate 40 mg/20 mL 2 mg/mL 20 mL SDV, 10/Bx

Frequently bought together

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Propofol 200 mg/20 mL 10 mg/mL 20 mL SDV, 25/Bx

Amidate 40 mg/20 mL 2 mg/mL 20 mL SDV, 10/Bx

Frequently bought together

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Lidocaine 2% 100 mg/5 mL 20 mg/mL 5 mL SDV, 10/Bx

Propofol 200 mg/20 mL 10 mg/mL 20 mL SDV, 25/Bx

Amidate 40 mg/20 mL 2 mg/mL 20 mL SDV, 10/Bx